Delivery Order SPE2DB22D2214-SPE2DB25FS4CH
Award Date
3/7/25
Potential Completion Date
3/10/25
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4,567,320 units of Ondansetron ODT 8 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $2,154.60 and is a firm fixed-price delivery order, with a completion date of February 21, 2025. This contract is a part of a...
This federal contract award, valued at $10,038.08, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,254,639 units of 4 mg Ondansetron HCL tablets, a medication used to prevent nausea and vomiting. The contract is a Firm Fixed Price Delivery Order with a completion date of February 13, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $18,787.18, is for the delivery of 4,566,947,023 units of Ondansetron HCL 4 mg tablets. This is a firm-fixed-price delivery order contract with a completion date of January 16, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, valued at $4,104.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,419,982 units of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of March 3, 2025 and is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,562,880 units of 8 mg Ondansetron Orally Disintegrating Tablets, with a ceiling value of $12,687.40 and a completion date of November 22, 2023. This is a firm-fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,254,788 tablets of 4 mg Ondansetron HCl, a medication used to prevent nausea and vomiting. The $12,053.89 firm fixed-price delivery order has a completion date of February 13, 2025 and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, worth $7,798.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,153,745 units of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. This is a firm-fixed-price delivery order contract, with a completion date of February 5, 2025. The contract is not designated as a set-aside award. In addition to...
This federal contract award, valued at $8,241.03, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ondansetron orally disintegrating tablets, a medication used to prevent nausea and vomiting. The contract is a Firm Fixed Price Delivery Order with a completion date of January 31, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,135,765 units of 4 mg Ondansetron Orally Disintegrating Tablets in 30-count packages. The contract has a ceiling value of $3,182.20 and runs through February 4, 2025. It is a firm-fixed-price delivery order contract. The contract is not designated as a set-aside....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,060 units of 4 mg Ondansetron HCL tablets, a medication used to prevent nausea and vomiting. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $19,736.83 and a performance period through January 28, 2025. AmerisourceBergen holds a significant Indefinite...